Electronic data collection in trials (what we do) also has limited reach in clinical trials as a whole right now. Most of the studies we support tend to be for pain medications (think post-operative pain) and more serious conditions, and that lets me sleep a bit better at night. I agree that certain drugs lines tend to be exploited more than others, and it can be easy to paint very broad strokes about pharma generally because of that exploitation.